Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study

This publication has 27 references indexed in Scilit:

• The β-Thalassemias
  New England Journal of Medicine, 1999
• NOVEL TREATMENT OPTIONS IN THE SEVERE β‐GLOBIN DISORDERS
  British Journal of Haematology, 1995
• Survival in Medically Treated Patients with Homozygous β-Thalassemia
  New England Journal of Medicine, 1994
• Beta-thalassemia unlinked to the beta-globin gene in an English family
  Blood, 1993
• Butyrate-induced reactivation of the fetal globin genes: A molecular treatment for theβ-hemoglobinophaties
  Cellular and Molecular Life Sciences, 1993
• Therapeutic Approaches to Hemoglobin Switching in Treatment of Hemoglobinopathies
  Annual Review of Medicine, 1992
• Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
  Proceedings of the National Academy of Sciences, 1988
• Pharmacological Manipulation of Fetal Hemoglobin Synthesis in Patients with Severe β‐Thalassemia
  Annals of the New York Academy of Sciences, 1985
• Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate.
  Proceedings of the National Academy of Sciences, 1984
• Interaction between Homozygous β⁰ Thalassaemia and the Swiss Type of Hereditary Persistence of Fetal Haemoglobin
  British Journal of Haematology, 1981